EA alleviates the inflammatory reaction by reducing the levels of serum pro-inflammatory cytokines such as IL-1, IL-1β, IL-6, IL-17, IL-23, and TNF-α in rheumatoid arthritis (RA) animal models [69] and IL-17 in the peripheral blood of RA patients [70]. The gene discussed is IL17A; the disease is rheumatoid arthritis.